Mirum Pharmaceuticals, Inc. (MIRM)
$79.62-7.48%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4.9B
- Beta
- 0.49
- P/E (TTM)
- -5.47
- Short % float
- 11.48%
- Days to cover
- 7.7
- SI change
- +11.2%
- 1W
- +0.47%
- 1M
- -17.71%
- vs SPY 1W
- +0.61%
- vs SPY 1M
- -20.21%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on MIRM?
- LOPJLB’s latest quantitative signal on Mirum Pharmaceuticals, Inc. (MIRM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MIRM in?
- Mirum Pharmaceuticals, Inc. (MIRM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Mirum Pharmaceuticals, Inc. (MIRM) do?
- Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixib…